HDT Bio Corp., a developer of immunotherapies for oncology and infectious diseases, announced today an…
dcorriganAugust 17, 2021
GentiBio is developing engineered regulatory T cells (Tregs) to build a better immune system and…
dcorriganAugust 16, 2021
Two postdoctoral researchers at Fred Hutchinson Cancer Research Center are among the 17 early career…
dcorriganAugust 16, 2021
Most work on the development of malaria vaccines happens in laboratory or clinical trials, where…
dcorriganAugust 13, 2021
Lumen Bioscience, a clinical-stage biopharmaceutical company developing products to treat and prevent highly prevalent diseases,…
dcorriganAugust 13, 2021
In the race to develop new and better vaccines and boosters to block COVID-19, scientists…
dcorriganAugust 13, 2021
Integrative Oncogene-Dependency Mapping Identifies RIT1 Vulnerabilities and Synergies in Lung Cancer
CRISPR-based cancer dependency maps are accelerating advances in cancer precision medicine, but adequate functional maps…
dcorriganAugust 12, 2021
Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. (Nasdaq: ADPT),…
dcorriganAugust 12, 2021
Eliem Therapeutics joined the ranks of publicly traded companies from Washington state, pricing 6.4 million shares…
dcorriganAugust 11, 2021
